Comparative Pharmacology
Head-to-head clinical analysis: A HYDROCORT versus ACTICORT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: A HYDROCORT versus ACTICORT.
A-HYDROCORT vs ACTICORT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Hydrocortisone is a corticosteroid hormone that binds to glucocorticoid receptors, modulating gene expression to suppress inflammation, inhibit immune response, and regulate metabolism.
Topical corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive actions. Suppresses cytokine production and inflammatory mediators via glucocorticoid receptor binding.
Adrenal insufficiency: oral 20-30 mg/day in divided doses; inflammatory conditions: 5-60 mg/day oral; IV/IM: hydrocortisone sodium succinate 50-100 mg every 4-6 hours.
5-60 mg orally once daily, or divided twice daily, depending on condition severity and response.
None Documented
None Documented
Terminal half-life: 1.5-2 hours (cortisol); clinical effect persists 8-12 hours due to glucocorticoid receptor binding
1.5-2.5 hours; prolonged in hepatic impairment (up to 10 hours) and renal impairment (up to 6 hours)
Renal (primarily as metabolites, <1% unchanged); biliary/fecal (<5%)
Renal (70% as unchanged drug and metabolites), biliary/fecal (30%)
Category C
Category C
Corticosteroid
Corticosteroid